Compumedics Limited provided earnings guidance for the year 2022. For the year, the company expects sales orders taken for FY22 expected to be at least $42 million, an, at least, 19% increase on FY21. Revenues expected to be around $35 million for FY22.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.225 AUD | -13.46% | -6.25% | -19.64% |
05-23 | Compumedics on Track to Reach Record Revenue in 2024, But Warns of Earnings Miss | MT |
02-29 | Compumedics Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-19.64% | 30.54M | |
+10.03% | 223B | |
+13.59% | 195B | |
+20.01% | 144B | |
+30.83% | 111B | |
+2.28% | 65.01B | |
+15.38% | 53.02B | |
+3.64% | 50.45B | |
+8.37% | 44.15B | |
+3.27% | 36.45B |
- Stock Market
- Equities
- CMP Stock
- News Compumedics Limited
- Compumedics Limited Provides Earnings Guidance for the Year 2022